Clinical Trial Detail
| NCT ID | NCT04093362 |
| Title | Futibatinib Vs Gemcitabine-Cisplatin Chemotherapy as 1st-Line Treatment of Patients With Advanced Cholangiocarcinoma (CCA) Harboring FGFR2 Gene Rearrangements (FOENIX-CCA3) |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Taiho Oncology, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |
CKB BOOST